Vascular events are risk factors for anal incontinence in systemic sclerosis: A study of morphology and functional properties measured by anal endosonography and manometry

Scandinavian Journal of Rheumatology

Volumn 43, Issue 5, 2014, Pages 391-397

  Bartosik, I ^a   Andreasson K ^a   Starck, M ^b   Scheja, A ^a   Hesselstrand, Roger ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; ANTIBODY;

ADULT; ANORECTAL PRESSURE; ANUS SPHINCTER; ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE DURATION; ENDOSCOPIC ECHOGRAPHY; FECES INCONTINENCE; FINGER ULCER; HUMAN; IMAGING SYSTEM; MANOMETRY; MIDDLE AGED; MORPHOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SCAR; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; AGED; ANAL CANAL; BLOOD; CASE CONTROL STUDY; CENTROMERE; COMORBIDITY; COMPLICATION; FECAL INCONTINENCE; FEMALE; FINGER; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; RECTUM; ULCER;

ADULT; AGED; ANAL CANAL; ANTIBODIES; CASE-CONTROL STUDIES; CENTROMERE; COMORBIDITY; ENDOSONOGRAPHY; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FECAL INCONTINENCE; FEMALE; FINGERS; HUMANS; MALE; MANOMETRY; MIDDLE AGED; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; ULCER; VASCULAR DISEASES;

EID: 84921709292     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.889210     Document Type: Article

References (25)

1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
2. Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 1998;27:563-94.
3. Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 2008;53:1163-74.
4. Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC Jr. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994;94:761-70.
5. Schmeiser T, Saar P, Jin D, Noethe M, Müller A, Soydan N, et al. Profile of gastrointestinal involvement in patients with systemic sclerosis. Rheumatol Int 2012;32:2471-8.
6. Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009;137:512-17.
7. Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003;21:S15-18.
8. Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999;34:409-13.
9. Koh CE, Young CJ, Wright CM, Byrne CM, Young JM. The internal anal sphincter in systemic sclerosis. Dis Colon Rectum 2009;52:315-18.
10. Herrick AL, Barlow JD, Bowden A, Williams N, Hobson AR, Irving M, Jayson MI. Investigation of anal function in patients with systemic sclerosis. Ann Rheum Dis 1996;55:370-4.
11. Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut 1999;44:77-80.
12. Frudinger A, Halligan S, Bartram CI, Price AB, Kamm MA, Winter R. Female anal sphincter: age-related differences in asymptomatic volunteers with high-frequency endoanal US. Radiology 2002;224:417-23.
13. Thoua NM, Schizas A, Forbes A, Denton CP, Emmanuel AV. Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology (Oxford) 2011;50:1596-602.
14. Fynne L, Worsoe J, Laurberg S, Krogh K. Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause? Scand J Rheumatol 2011;40:462-6.
15. Thoua NM, Abdel-Halim M, Forbes A, Denton CP, Emmanuel AV. Fecal incontinence in systemic sclerosis is secondary to neuropathy. Am J Gastroenterol 2012;107:597-603.
16. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
17. Wildt M, Hesselstrand R, Åkesson A, Scheja A. Simple counting of nailfold capillary density in systemic sclerosis - 9 years' experience. Scand J Rheumatol 2007;36:452-7.
18. Andréasson K, Scheja A, Saxne T, Ohlsson B, Hesselstrand R. Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med 2011;270:50-7.
19. Starck M, Bohe M, Fortling B, Valentin L. Endosonography of the anal sphincter in women of different ages and parity. Ultrasound Obstet Gynecol 2005;25:169-76.
20. Starck M, Bohe M, Valentin L. The extent of endosonographic anal sphincter defects after primary repair of obstetric sphincter tears increases over time and is related to anal incontinence. Ultrasound Obstet Gynecol 2006;27:188-97.
21. Fynne L, Luft F, Gregersen H, Buntzen S, Lundby L, Lundager F, et al. Distensibility of the anal canal in patients with systemic sclerosis: a study with the functional lumen imaging probe. Colorectal Dis 2013;15:e40-7.
22. Belsh JJ, Land D, Park RH, McKillop JH, MacKenzie JF. Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol 1988;27:426-30.
23. Hesselstrand R, Wuttge DM, Wildt M, Ekmehag B, Scheja A. Survival in patients with pulmonary arterial hypertension associated with connective tissue disease from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol 2011;40:127-32.
24. Ceribelli A, Cavazzana I, Airò P, Franceschini F. Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis. J Rheumatol 2010;37:1544.
25. Gherenassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol 2014;41:99-105.